Beta glycolipids for the treatment of calcification related degenerative disorders

A kit for achieving a therapeutic effect in a subject in need thereof comprising:

• a. at least one natural or synthetic β-glycolipid, mixture of at least two β-glycolipids, a substance which increases the intracellular, extracellular or serum level of a naturally occurring β-glycolipid;
• or any combination or mixture thereof, or a pharmaceutically acceptable derivative thereof and a pharmaceutically acceptable carrier or diluent optionally, in a first unit dosage form;
• b. at least one phosphate inhibitor or any compound that alters the phosphate binding or transporting into or out of any cell or any membrane or any combination thereof and a pharmaceutically acceptable carrier or diluent, optionally, in a second unit dosage form;
• and
• c. container means for containing said first and second dosage forms.

A method for the treatment or prevention of a calcification related degenerative disorder in a subject in need thereof, which method comprises the step of administering to said subject a therapeutically effective amount of at least one of:

• a. at least one of a natural or synthetic β-glycolipid, a mixture of at least two β-glycolipids, a substance which increases the intracellular, extracellular or serum level of a naturally occurring β-glycolipid;
• b. at least one phosphate inhibitor or any compound that alters the phosphate binding or transporting into or out of any cell or any membrane or any combination thereof;
• and
• c. a composition or kit comprising (a) or (b) or of any combinations thereof.